Potent P2Y12 inhibitors versus clopidogrel to predict adherence to antiplatelet therapy after an acute coronary syndrome: insights from IDEAL-LDL-Reference-Cited by-同舟云学术

Potent P2Y12 inhibitors versus clopidogrel to predict adherence to antiplatelet therapy after an acute coronary syndrome: insights from IDEAL-LDL

Published:2022-03-03 Issue:3 Volume:23 Page:081
ISSN:1530-6550
Container-title:Reviews in Cardiovascular Medicine
language:en
Short-container-title:Rev. Cardiovasc. Med.

Author:

Kourti Olga,Konstantas Orestis,Farmakis Ioannis Τ,Zafeiropoulos Stefanos,Psarakis Georgios,Vrana Elena,Baroutidou Amalia,Graidis Spyridon,Touriki Aikaterini-Vassiliki,Tsolakidis Christos,Spyridaki Konstantina,Psathas Thomas,Daniilidou Anastasia,Karvounis Haralambos,Giannakoulas George

Publisher

IMR Press

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Patient Adherence to Dual Antiplatelet Medication Following Percutaneous Coronary Intervention on the Occurrence of Adverse Cardiovascular Events;Patient Preference and Adherence;2024-02

2. Acute Coronary Syndromes in Women: A Narrative Review of Sex-Specific Characteristics;Angiology;2023-11-23

3. The Efficacy and Safety of Proton Pump Inhibitors Combining Dual Antiplatelet Therapy in Patients with Coronary Intervention: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials;Reviews in Cardiovascular Medicine;2023-08-09

4. The Pathophysiology of Acute Coronary Syndrome;Reviews in Cardiovascular Medicine;2023-07-21

5. Dual Antiplatelet Therapy;Atrial Fibrillation - Diagnosis and Management in the 21st Century;2022-11-30